Chemistry: molecular biology and microbiology – Micro-organism – per se ; compositions thereof; proces of... – Bacteria or actinomycetales; media therefor
Reexamination Certificate
2003-10-15
2010-02-16
Vogel, Nancy (Department: 1636)
Chemistry: molecular biology and microbiology
Micro-organism, per se ; compositions thereof; proces of...
Bacteria or actinomycetales; media therefor
C435S069100
Reexamination Certificate
active
07662609
ABSTRACT:
The present invention provides anEcolihost cell expressing a recombinant antibody characterized in that theEcolihost cell has been genetically modified in order to change at least one physical property of one or moreEcoliproteins which in the wild type copurify with said recombinant antibody.
REFERENCES:
patent: 4532207 (1985-07-01), Brewer et al.
patent: 5304472 (1994-04-01), Bass et al.
patent: 5783423 (1998-07-01), Wood et al.
patent: 737 747 (1996-10-01), None
patent: 224082 (1924-11-01), None
patent: WO 98/18946 (1998-05-01), None
patent: WO 00/61725 (2000-10-01), None
patent: WO 2004/031188 (2004-04-01), None
patent: WO 2004/035792 (2004-04-01), None
Shuman, J. Biol. Chem. 257(10), 5455-5461, 1982.
Amemura, M., et al., “Cloning of and complementation tests with alkaline phosphatase regulatory genes (phoSandphoT) ofEscherichia coli,” J. of Bacteriology, 1982, 152(2), 692-701.
Blattner, F.R., et al., “The complete genome sequence ofEscherichia coliK-12,”Science, 1997, 277, 1453-1462.
Blomfield, I.C., et al., “Allelic exchange inEscherichia coliusing theBacillus subtilis sacBgene and a temperature-sensitive pSC101 replicon,”Molecular Microbiology, 1991, 5(6), 1447-1457.
Carrier, A., et al., “recombinant antibody-alkaline phosphatase conjugates for diagnosis of human IgGs: application to anti-HBsAg detection,”J. of Immunological Methods, 1995, 181, 177-186.
Collins-Racie, L.A., et al., “Production of recombinant bovine enterokinase catalytic subunit inEscherichia coliusing the novel secretory fusion partner DsbA,”Bio/Technology, 1995, 13, 982-987.
Cunningham, B.C., et al., “High-resolution epitope mapping of hGH-Receptor interations by alanine-scanning mutagenesis,”Science, 1989, 244, 1081-1085.
Dalbøge, H., et al., “A novel enzymatic method for production of authentic hGH from anEscherichia coliproduced hGH-precursor,”Bio/Technology, 1987, 5, 161-164.
di Guan, C., et al., “Vectors that facilitate the expression and purification of foreign peptides inEscherichia coli, by fusion to maltose-binding protein,”Gene, 1988, 67, 21-30.
Egmond, M.R., et al., “Engineering surface charges in a subtilisin,” inSubtilisin Enzymes: Practical protein Engineering, Bott, R., et al.(Eds.), 1996, 219-228.
Gräslund, T., et al., “Strategy for highly selective ion-exchange capture using a charge-polarizing fusion partner,”J. of Chromatography A, 2002, 942, 157-166.
Gräslund, T., et al., “Charge engineering of a protein domain to allow efficient ion-exchange recovery,”Protein Engineering, 2000, 13(10), 703-709.
Hamilton, C.M., et al., “New method for generating deletions and gene replacements inEscherichia coli,” J. of Bacteriology, 1989, 171(9), 4617-1622.
Humphreys, D.P., et al., “Therapeutic antibody production technologies: molecules, applications, expression and purification,”Current Opinion in Drug Discovery and Development, 2001, 4(2), 172-185.
Jonasson, P., et al., “Genetic design for facilitated production and recovery of recombinant proteins inEscherichia coli,” Biotechnology&Applied Biochemistry, England, 2002, 35, 91-105.
Link, A.J., et al., “Methods for generating precise deletions and insertions in the genome of wild-typeEscherichia coli: application to open reading frame characterization,”J. of Bacteriology, 1997, 179(20), 6228-6237.
Luecke, H., et al., “High specificity of a phosphate transport protein determined by hydrogen bonds,”Nature, 1990, 347, 402-406.
Marttila, A.T., et al., “Engineering of chicken avidin: a progressive series of reduced charge mutants,”FEBS Letts., 1998, 441, 313-317.
Meyer, D.E., et al., “Purification of recombinant proteins by fusion with thermally-responsive polypeptides,”Nature Biotechnology, 1999, 17, 1112-1115.
Mhatre, R., et al., “Purification of antibody Fab fragments by cation-exchange chromatography and pH gradient elution,”J. of Chromatography A, 1995, 707, 225-231.
Niederauer, M.Q., et al., “Characterization and polyelectrolyte of β- galactosidase containing genetic fusions of charged polypeptides,”Biotechnology Progress, 1994, 10, 237-245.
Nielsen, O.J., et al., “Erythropoietin-β-D-galactosidase: the generation, purification and use of a fusion protein,”J. of Immunological Methods, 1988, 111, 1-9.
O'Brien, P.M., et al., “Bacterial expression and purification of recombinant,”Protein Expression&Purification, 2002, 24, 43-50.
Ong, E., et al., “Enzyme immobilization using the cellulose-binding domain of aCellulomonas fimiexoglucanase,”Bio/Technology, 1989, 7, 604-607.
Persson, M., et al., “Enzyme purification by genetically attached polycysteine and polyphenylalanine affinity tails,”Analytical Biochemistry, 1988, 172, 330-337.
Plückthun, A., et al., “New protein engineering approaches tomultivalent and bispecific antibody fragments,”Immunotechnology, 1997, 3, 83-105.
Sassenfeld, H.M., et al., “A polypeptide fusion designed for the purification of recombinant proteins,”Bio/technology, 1984, 2, 76-81.
Sassenfeld, H.M., “Engineering proteins for purification,”Tibtech, 1990, 8, 88-93.
Smith, D.B., et al., “Single-step purification of polypeptides expressed inEscherichia colias fusions with glutathione S-transferase,”Gene, 1988, 67, 31-40.
Stempfer, G., et al., “Improved refolding of an immobilized fusion protein,”Nature Biotechnology, 1996, 14, 329-334.
Verma, R., et al., “Antibody engineering: comparison of bacterial, yeast, insect and mammalian expression system,”J. of Immunological Methods, 1998, 216, 165-181.
Zoller, M.J., et al., “Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA,”Nucleic Acid Res., 1982, 10(20), 6487-6500.
Chapman Andrew Paul
Humphreys David Paul
Robinson Martyn Kim
Spitali Mariangela
McDonnell Boehnen & Hulbert & Berghoff LLP
UCB Pharma S.A.
Vogel Nancy
LandOfFree
E.coli host cells with modified PhoS/PstS periplasmic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with E.coli host cells with modified PhoS/PstS periplasmic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and E.coli host cells with modified PhoS/PstS periplasmic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4176023